The FDA approved the first ultrasound system for imaging dense breast tissue on Tuesday. The somo-v Automated Breast Ultrasound System (ABUS) is intended for use in women with dense tissue who’ve had a negative mammogram and no symptoms of breast cancer.
In a clinical study of some 200 women with dense breast tissue, cancer was detected significantly more often when board-certified radiologists reviewed mammograms along with somo-v ABUS images than when they reviewed mammograms alone.
Source: FDA